Nuveen’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $34.9M | Buy |
1,494,645
+11,643
| +0.8% | +$253K | 0.01% | 817 |
|
|
2025
Q4 | $31.2M | Buy |
1,483,002
+7,204
| +0.5% | +$126K | 0.01% | 882 |
|
|
2025
Q3 | $22.7M | Buy |
1,475,798
+1,209,755
| +455% | +$15.8M | 0.01% | 1069 |
|
|
2025
Q2 | $2.49M | Buy |
266,043
+41,890
| +19% | +$461K | ﹤0.01% | 2208 |
|
|
2025
Q1 | $2.75M | Sell |
224,153
-209,905
| -48% | -$2.96M | ﹤0.01% | 2194 |
|
|
2024
Q4 | $5.74M | Sell |
434,058
-25,474
| -6% | -$436K | ﹤0.01% | 1920 |
|
|
2024
Q3 | $8.85M | Sell |
459,532
-96,882
| -17% | -$2M | ﹤0.01% | 1688 |
|
|
2024
Q2 | $11.4M | Buy |
556,414
+163,728
| +42% | +$3.43M | ﹤0.01% | 1501 |
|
|
2024
Q1 | $9.35M | Sell |
392,686
-231,324
| -37% | -$5.16M | ﹤0.01% | 1636 |
|
|
2023
Q4 | $13.5M | Buy |
624,010
+450,571
| +260% | +$6.93M | ﹤0.01% | 1396 |
|
|
2023
Q3 | $2.52M | Buy |
173,439
+12,492
| +8% | +$236K | ﹤0.01% | 2207 |
|
|
2023
Q2 | $3.37M | Buy |
160,947
+9,710
| +6% | +$202K | ﹤0.01% | 2105 |
|
|
2023
Q1 | $3.19M | Buy |
151,237
+6,375
| +4% | +$159K | ﹤0.01% | 2131 |
|
|
2022
Q4 | $3.69M | Sell |
144,862
-21,015
| -13% | -$490K | ﹤0.01% | 2087 |
|
|
2022
Q3 | $3.99M | Buy |
165,877
+35
| +0% | +$785 | ﹤0.01% | 2030 |
|
|
2022
Q2 | $3.19M | Buy |
165,842
+2,252
| +1% | +$37.5K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $2.77M | Sell |
163,590
-271
| -0.2% | -$4.56K | ﹤0.01% | 2364 |
|
|
2021
Q4 | $2.93M | Sell |
163,861
-10,809
| -6% | -$200K | ﹤0.01% | 2379 |
|
|
2021
Q3 | $3.46M | Sell |
174,670
-42,244
| -19% | -$704K | ﹤0.01% | 2415 |
|
|
2021
Q2 | $3.73M | Buy |
216,914
+78,723
| +57% | +$1.44M | ﹤0.01% | 2396 |
|
|
2021
Q1 | $3.09M | Sell |
138,191
-18,147
| -12% | -$410K | ﹤0.01% | 2407 |
|
|
2020
Q4 | $3.48M | Sell |
156,338
-30,303
| -16% | -$628K | ﹤0.01% | 2250 |
|
|
2020
Q3 | $2.75M | Buy |
186,641
+69,338
| +59% | +$1.06M | ﹤0.01% | 2223 |
|
|
2020
Q2 | $1.74M | Buy |
117,303
+42,266
| +56% | +$644K | ﹤0.01% | 2400 |
|
|
2020
Q1 | $824K | Sell |
75,037
-14,119
| -16% | -$133K | ﹤0.01% | 2598 |
|
|
2019
Q4 | $783K | Sell |
89,156
-59,832
| -40% | -$439K | ﹤0.01% | 2773 |
|
|
2019
Q3 | $1.11M | Buy |
148,988
+39,756
| +36% | +$362K | ﹤0.01% | 2656 |
|
|
2019
Q2 | $1.02M | Buy |
+109,232
| New | +$796K | ﹤0.01% | 2731 |
|
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM